How Keel was paid
$10.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Paul KeelPresident & CEO | $1,100,000 | $5,440,152 | $1,360,045 | $2,486,550 | $172,820 | $10,559,567 |
| Eric HammesChief Financial Officer | $592,308 | $975,153 | $325,009 | $739,800 | $13,700 | $2,645,970 |
| Mark NanceSVP and General Counsel | $559,615 | $1,125,143 | $375,017 | $551,425 | $33,986 | $2,645,186 |
| Veronica AcurioPresident, Orthodontics | $550,000 | $637,674 | $212,513 | $720,720 | $52,197 | $2,173,104 |
| Robert BefidiPresident, Diagnostics | $567,308 | $637,674 | $212,513 | $470,925 | $47,847 | $1,936,267 |
What changed and why
- $10.6MPaul Keel received total compensation of $10,559,567 in 2025 following his appointment as CEO.
- 6.5%Total revenue reached $2,719,500,000 with core sales growth of 6.5% for the fiscal year.
- $371.7MAdjusted EBITDA improved to $371,700,000 compared to $296,100,000 in the prior year.
- 94.3%The 2025 say-on-pay proposal received 94.3% support from stockholders at the annual meeting.
- The CEO to median employee pay ratio was approximately 183 to 1.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.